<DOC>
	<DOCNO>NCT01308645</DOCNO>
	<brief_summary>The purpose study determine efficacy SB injection Hepatocellular Carcinoma ( HCC ) .</brief_summary>
	<brief_title>Evaluating Safety Efficacy SB Injection Patients With Advanced Primary Hepatocellular Carcinoma ( HCC )</brief_title>
	<detailed_description>All eligible patient receive SB injection therapy 6 cycle ( 14~21 day cycle ) . Efficacy wll evaluate every 3 cycle .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>1 . Age 18 year 2 . Patients Hepatocellular carcinoma progression ( HCC ) primary liver cancer diagnostic image test ( eg , Xray , CT , scan , ultrasound ) measure patient lesion 3 . Directly standard therapy ( surgery , RF ablation , TACE ) possible , patient advance liver cancer . However , standard treatment subject subject entirely voluntary participation subject participate discretion doctor researcher deem included select target . 4 . Life expectancy â‰¥ 5 month 5 . ECOG status 0 , 1 , 2 patient 6 . ChildPugh classification A , B patient 7 . PLT 70,000 , ANC 1,000 patient ( OT / PT &lt; upper normal limit x 5.0 , Bilirubin &lt; upper normal limit x 3.0 ) 8 . Female volunteer admit study must use reliable mean contraception must negative blood urine pregnancy test least 7 day ago 9 . Patients legal representative sign informed consent form 1 . Last 4 week patient participate another clinical trial 2 . Last 4 week patient receive chemotherapy 3 . Associated hepatocellular carcinoma patient history malignant tumor 4 . Hepatectomy liver transplantation patient receive treatment . 5 . Active systemic infection require medical treatment 6 . Uncontrolled hypertension diabetes mellitus . 7 . Clinically Significant cardiac disease ( myocardial infarction / angina / severe arrhythmia / congestive heart failure ) 8 . Autoimmune diseases ( systemic lupus erythematosus : SLE / rheumatoid arthritis / myasthenia gravis ) patient currently treat 9 . Presence history malignancy Hepatocellular carcinoma within 5 year 10 . Patients history allergy investigational drug . 11 . Obvious cognitive physical impairment would prevent participation 12 . Pregnancy , lactation period n't use contraception earnest Patients</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>SBP Injection</keyword>
	<keyword>HCC</keyword>
</DOC>